Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Exp Allergy ; 45(1): 273-82, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24666565

RESUMO

BACKGROUND: Vitamin D deficiency may be associated with an increased risk of asthma. OBJECTIVE: We studied the association between 25-hydroxy (25-OH) vitamin D deficiency and asthma prevalence in two Peruvian populations close to the equator but with disparate degrees of urbanization. METHODS: We conducted a population-based study in 1441 children in two communities in Peru, of which 1134 (79%) provided a blood sample for 25-OH vitamin D analysis. RESULTS: In these 1134 children, mean age was 14.8 years; 52% were boys; asthma and atopy prevalence was 12% in Lima vs. 3% in Tumbes (P < 0.001) and 59% in Lima vs. 41% in Tumbes (P < 0.001), respectively; and, mean 25-OH vitamin D level was 20.8 ng/mL in Lima vs. 30.1 ng/mL in Tumbes (P < 0.001). Prevalence of 25-OH vitamin D deficiency (< 20 ng/mL) was 47% in Lima vs. 7% in Tumbes (P < 0.001). In multi-variable logistic regression, we found that lower 25-OH vitamin D levels were associated with an increased odds of asthma (OR = 1.7 per each 10 ng/mL decrease in 25-OH vitamin D levels, 95% CI 1.2-2.6; P < 0.01). In stratified analyses, the association between lower 25-OH vitamin D levels and asthma was limited to children with atopy (OR = 2.2, 95% CI 1.3-3.6) and not in those without atopy (OR = 0.9, 95% CI 0.5-2.0). We did not find associations between 25-OH vitamin D levels and other clinical biomarkers for asthma, including exhaled nitric oxide, total serum IgE and pulmonary function. CONCLUSION AND CLINICAL RELEVANCE: Both asthma and 25-OH vitamin D deficiency were common among children living in Lima (latitude = 12.0 °S) but not among those in Tumbes (3.6 °S). The relationship between 25-OH vitamin D deficiency and asthma was similar in both sites and was limited among children with atopy. Future supplementation trials may need to consider stratification by atopy at the time of design.


Assuntos
Asma/sangue , Asma/epidemiologia , Calcifediol/sangue , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/epidemiologia , Adolescente , Asma/complicações , Feminino , Humanos , Masculino , Peru/epidemiologia , Deficiência de Vitamina D/complicações
2.
Curr Biol ; 10(17): 1059-62, 2000 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-10996074

RESUMO

The arrangement of Hox genes into physical clusters is fundamental to the patterning of animal body plans. Other homeobox genes are often described as dispersed, with only occasional examples of linkage reported, such as the amphioxus ParaHox and Drosophila 93D/E clusters. This clustering is unlikely to be the derived condition, as the genes of the ParaHox and 93D/E clusters are phylogenetically widespread. To assess whether clustering is retained in mammals, and to infer its history, we considered the distribution of ANTP superclass homeobox genes in human and mouse genomes. We postulate four ancient arrays of ANTP superclass genes in animal genomes, denoted 'extended Hox' (Hox, Evx and Mox), NKL (including NK1, NK3, NK4, Lbx, Tlx, Emx, Vax, Hmx, NK6, Msx), ParaHox (Cdx, Xlox, Gsx) and EHGbox (En, HB9, Gbx). Each of these duplicated in the ancestry of the human genome to yield four Hox, four NKL, four ParaHox and at least two EHGbox clusters or arrays. Two of the human NKL clusters (four in mouse) have subsequently been split by chromosome rearrangement, as has one human EHGbox array. We date all cluster duplications to early chordate evolution and infer that three clusters (Hox, NKL, EHGbox) resided on the same chromosome before duplication.


Assuntos
Genes Homeobox , Genoma Humano , Família Multigênica , Animais , Duplicação Gênica , Ligação Genética , Humanos , Camundongos
3.
J Neurol Sci ; 76(2-3): 239-53, 1986 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-3025377

RESUMO

Mice with the inherited disorder "motor end-plate disease" suffered from a progressive neuromuscular weakness and muscular wasting. The weakness resulted from a failure of evoked transmitter release from the motor nerve terminals. The failure in transmission was all-or-nothing in nature. The numbers of muscle fibres in skeletal muscle and myelinated axons in several major nerve trunks were no different from normal. The loss in muscle bulk was caused by the neuromuscular defect and not from a loss of motor units or muscle fibres. The inherited murine disorder "jolting" was allelic with "motor end-plate disease". Affected "jolting" mice suffered no detectable morphological abnormality in skeletal muscle or peripheral nerve. The physiological properties of skeletal muscle and the characteristics of neuromuscular transmission were indistinguishable from normal.


Assuntos
Doenças Neuromusculares/fisiopatologia , Junção Neuromuscular/fisiopatologia , Transmissão Sináptica , Potenciais de Ação , Fatores Etários , Animais , Contagem de Células , Estimulação Elétrica , Feminino , Masculino , Potenciais da Membrana , Camundongos , Camundongos Mutantes Neurológicos , Placa Motora/fisiopatologia , Músculos/patologia , Músculos/fisiopatologia , Fibras Nervosas Mielinizadas/patologia , Doenças Neuromusculares/patologia , Junção Neuromuscular/patologia , Nervos Periféricos/patologia
4.
Br J Pharmacol ; 84(1): 6-8, 1985 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2983805

RESUMO

Motor endplate disease (med) in the mouse is an hereditary disorder of the skeletal neuromuscular system. Affected animals suffer a 'functional denervation' of skeletal muscle (Duchen & Stefani, 1971). Muscle fibres do not respond to indirect excitation, but motor nerve terminals release transmitter spontaneously. Spontaneous transmitter release can be enhanced by raising [K+]o or by exposing muscles to red-back spider venom and functional transmission following indirect stimulation may be restored by 4-aminopyridine.


Assuntos
Aminopiridinas/uso terapêutico , Placa Motora/fisiopatologia , Doenças Neuromusculares/genética , Junção Neuromuscular/fisiopatologia , Paralisia/tratamento farmacológico , 4-Aminopiridina , Animais , Camundongos , Doenças Neuromusculares/complicações , Doenças Neuromusculares/fisiopatologia , Paralisia/etiologia , Paralisia/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...